Pubmed数据库中,下列检索表达式正确的是() A: Cell[ab] B: "Arrhythmias, Cardiac/dt"[Mesh] C: "Arrhythmias, Cardiac/drug therapy"[Mh] D: “arrhythmias, cardiac”[Mesh terms]
Pubmed数据库中,下列检索表达式正确的是() A: Cell[ab] B: "Arrhythmias, Cardiac/dt"[Mesh] C: "Arrhythmias, Cardiac/drug therapy"[Mh] D: “arrhythmias, cardiac”[Mesh terms]
Angina pectoris, tachycardia, and arrhythmias are possible adverse effects of which of the following agonists? A: α2-agonist B: α1-agonist C: β3-agonist D: β1-agonist
Angina pectoris, tachycardia, and arrhythmias are possible adverse effects of which of the following agonists? A: α2-agonist B: α1-agonist C: β3-agonist D: β1-agonist
Drug X is used in the treatment of cardiac arrhythmias. It is not recommended for use in asthmatic patients because of effects on certain adrenoceptors. This drug is probably A: procainamide B: propranolol C: quinidine D: lidocaine E: phenytonin
Drug X is used in the treatment of cardiac arrhythmias. It is not recommended for use in asthmatic patients because of effects on certain adrenoceptors. This drug is probably A: procainamide B: propranolol C: quinidine D: lidocaine E: phenytonin
Your doctor will ask about your family ( ) of heart disease, cardiac arrhythmias and fainting spells A: culture B: history C: member D: condition
Your doctor will ask about your family ( ) of heart disease, cardiac arrhythmias and fainting spells A: culture B: history C: member D: condition
Among the<br/>following local anesthetics, which one can be used to treat<br/>ventricular arrhythmias? () A: Bupivacaine B: Lidocaine C: Tetracaine D: Procaine E: Ropivacaine
Among the<br/>following local anesthetics, which one can be used to treat<br/>ventricular arrhythmias? () A: Bupivacaine B: Lidocaine C: Tetracaine D: Procaine E: Ropivacaine
All of the following measures could be used in the treatment of digoxin-induced arrhythmias EXCEPT A: stopping digoxin administration B: electrical conversion C: phenytoin administration D: lidocaine administration E: atropine administration
All of the following measures could be used in the treatment of digoxin-induced arrhythmias EXCEPT A: stopping digoxin administration B: electrical conversion C: phenytoin administration D: lidocaine administration E: atropine administration
Propranolol is A: effective in the treatment of supraventricular arrhythmias B: effective in all angina pectoris cases by increasing the O2 supply C: lowers the blood pressure by reducing the renin synthesis D: cardioselective and having a partial agonist activity
Propranolol is A: effective in the treatment of supraventricular arrhythmias B: effective in all angina pectoris cases by increasing the O2 supply C: lowers the blood pressure by reducing the renin synthesis D: cardioselective and having a partial agonist activity
Which of the following arrhythmias can not be treated with Lidocaine?() A: ventricular fibrillation B: premature ventricualr contraction caused by AMI C: supraventricular tachycardia D: premature ventricualr contraction E: ventricular arrhythmia induced by cardiac glycoside intoxication
Which of the following arrhythmias can not be treated with Lidocaine?() A: ventricular fibrillation B: premature ventricualr contraction caused by AMI C: supraventricular tachycardia D: premature ventricualr contraction E: ventricular arrhythmia induced by cardiac glycoside intoxication
The adverse reactions of fluoroquinolones including the following EXCEPT: A: Tendinitis and tendon rupture B: Effects on bony structure and teeth C: Allergic effect: skin rash, phototoxicity D: Cardiac arrhythmias: QT interval prolongation E: Hepatotoxicity and nephrotoxicity
The adverse reactions of fluoroquinolones including the following EXCEPT: A: Tendinitis and tendon rupture B: Effects on bony structure and teeth C: Allergic effect: skin rash, phototoxicity D: Cardiac arrhythmias: QT interval prolongation E: Hepatotoxicity and nephrotoxicity
suppression of arrhythmias resulting from a reentry focus is most likely to occur if the drug A: has vagomimetic effects o the AV node B: is a beta-blocker C: converts a unidirectional block to a bidrectional block D: slows conduction through the atria E: has atropine-like effects on the AV node
suppression of arrhythmias resulting from a reentry focus is most likely to occur if the drug A: has vagomimetic effects o the AV node B: is a beta-blocker C: converts a unidirectional block to a bidrectional block D: slows conduction through the atria E: has atropine-like effects on the AV node